<VariationArchive VariationID="217156" VariationName="NM_000070.3(CAPN3):c.483del (p.Ile162fs)" VariationType="Deletion" Accession="VCV000217156" Version="10" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-08" DateCreated="2015-10-19" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="213821" VariationID="217156">
      <GeneList>
        <Gene Symbol="CAPN3" FullName="calpain 3" GeneID="825" HGNC_ID="HGNC:1480" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q15.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="42359501" stop="42412317" display_start="42359501" display_stop="42412317" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="42651697" stop="42704514" display_start="42651697" display_stop="42704514" Strand="+" />
          </Location>
          <OMIM>114240</OMIM>
        </Gene>
        <Gene Symbol="LOC126862115" FullName="BRD4-independent group 4 enhancer GRCh37_chr15:42677734-42678933" GeneID="126862115" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q15.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="42385536" stop="42386735" display_start="42385536" display_stop="42386735" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000070.3(CAPN3):c.483del (p.Ile162fs)</Name>
      <CanonicalSPDI>NC_000015.10:42386267:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q15.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="42386268" stop="42386268" display_start="42386268" display_stop="42386268" variantLength="1" positionVCF="42386267" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="42678466" stop="42678466" display_start="42678466" display_stop="42678466" variantLength="1" positionVCF="42678465" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>I162fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.42386270del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.42386270del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.42678468del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.42678468del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008660.1" sequenceAccession="NG_008660" sequenceVersion="1" change="g.43168del">
            <Expression>NG_008660.1:g.43168del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000070.3" sequenceAccession="NM_000070" sequenceVersion="3" change="c.483del" MANESelect="true">
            <Expression>NM_000070.3:c.483del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000061.1" sequenceAccession="NP_000061" sequenceVersion="1" change="p.Ile162fs">
            <Expression>NP_000061.1:p.Ile162fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024344.2" sequenceAccession="NM_024344" sequenceVersion="2" change="c.483del">
            <Expression>NM_024344.2:c.483del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_077320.1" sequenceAccession="NP_077320" sequenceVersion="1" change="p.Ile162fs">
            <Expression>NP_077320.1:p.Ile162fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_173087.2" sequenceAccession="NM_173087" sequenceVersion="2" change="c.483del">
            <Expression>NM_173087.2:c.483del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_775110.1" sequenceAccession="NP_775110" sequenceVersion="1" change="p.Ile162fs">
            <Expression>NP_775110.1:p.Ile162fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_849" sequenceAccession="LRG_849">
            <Expression>LRG_849:g.43168del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_849t1" sequenceAccession="LRG_849t1">
            <Expression>LRG_849t1:c.483del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_849p1" sequenceAccession="LRG_849p1" change="p.Ile162fs">
            <Expression>LRG_849p1:p.Ile162fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA347477" DB="ClinGen" />
        <XRef Type="rs" ID="863224963" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000070.3(CAPN3):c.483del (p.Ile162fs) AND not provided" Accession="RCV000201022" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-08-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000070.3(CAPN3):c.483del (p.Ile162fs) AND Autosomal recessive limb-girdle muscular dystrophy type 2A" Accession="RCV001004958" Version="7">
        <ClassifiedConditionList TraitSetID="5780">
          <ClassifiedCondition DB="MedGen" ID="C1869123">Autosomal recessive limb-girdle muscular dystrophy type 2A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-20" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000070.3(CAPN3):c.483del (p.Ile162fs) AND Muscular dystrophy, limb-girdle, autosomal dominant 4" Accession="RCV003462348" Version="1">
        <ClassifiedConditionList TraitSetID="44661">
          <ClassifiedCondition DB="MedGen" ID="C4748295">Muscular dystrophy, limb-girdle, autosomal dominant 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-20" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2015-10-19" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10330340</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15689361</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16650086</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21172462</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25079074</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="44661" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="40660" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1I</ElementValue>
                <XRef Type="MIM" ID="618129" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy, limb-girdle, autosomal dominant 4</ElementValue>
                <XRef ID="MONDO:0029133" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LGMDD4</ElementValue>
                <XRef Type="MIM" ID="618129" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LGMD1I</ElementValue>
                <XRef Type="MIM" ID="618129" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301490</ID>
                <ID Source="BookShelf">NBK1313</ID>
              </Citation>
              <XRef ID="C4748295" DB="MedGen" />
              <XRef ID="MONDO:0029133" DB="MONDO" />
              <XRef Type="MIM" ID="618129" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5780" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3064" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2A</ElementValue>
                <XRef ID="MONDO:0009675" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2A</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy%2C+type+2A/4236" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Calpainopathy</ElementValue>
                <XRef ID="NBK1313" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, pelvofemoral</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leyden-Moebius muscular dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, limb-girdle, type 2A, Amish</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR1</ElementValue>
                <XRef Type="MIM" ID="253600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LGMD2</ElementValue>
                <XRef Type="MIM" ID="253600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1057" />
                <XRef ID="1057" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Calpainopathy is characterized by symmetric and progressive weakness of proximal limb-girdle muscles. The age at onset of muscle weakness ranges from two to 40 years. The phenotype shows intra- and interfamilial variability ranging from severe to mild. Three autosomal recessive calpainopathy phenotypes have been identified based on the distribution of muscle weakness and age at onset: Pelvifemoral limb-girdle muscular dystrophy (LGMD) (Leyden-MÃ¶bius LGMD) phenotype, the most frequently observed calpainopathy phenotype, in which muscle weakness is first evident in the pelvic girdle and later in the shoulder girdle, with onset that may occur as early as before age 12 years or as late as after age 30 years. Scapulohumeral LGMD (Erb LGMD) phenotype, usually a milder phenotype with infrequent early onset, in which muscle weakness is first evident in the shoulder girdle and later in the pelvic girdle. HyperCKemia, usually observed in children or young individuals, in which individuals are asymptomatic and have high serum creatine kinase (CK) concentrations. The autosomal dominant form of calpainopathy shows a variability of clinical phenotype, ranging from almost asymptomatic to wheelchair dependence after age 60 years in few cases with a generally milder phenotype than the recessive form. Clinical findings of calpainopathy include the tendency to walk on tiptoe, difficulty in running, scapular winging, waddling gait, and slight hyperlordosis. Other findings include symmetric weakness of proximal more than distal muscles in the limbs, trunk, and periscapular area; laxity of the abdominal muscles; Achilles tendon shortening; scoliosis; and joint contractures. Affected individuals typically do not have cardiac involvement or intellectual disability.</Attribute>
                <XRef ID="NBK1313" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000557704" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000560317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511445" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332444" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521018" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530423" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301490</ID>
                <ID Source="BookShelf">NBK1313</ID>
              </Citation>
              <XRef ID="267" DB="Orphanet" />
              <XRef ID="C1869123" DB="MedGen" />
              <XRef ID="MONDO:0009675" DB="MONDO" />
              <XRef Type="MIM" ID="253600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="476464" SubmissionDate="2019-09-25" DateLastUpdated="2020-01-18" DateCreated="2015-10-19">
        <ClinVarSubmissionID localKey="1979943|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000255665" DateUpdated="2020-01-18" DateCreated="2015-10-19" Type="SCV" Version="3" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16650086</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21172462</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25079074</ID>
          </Citation>
          <Comment>The variant results in a shift of the reading frame, and is therefore predicted to significantly disrupt the protein structure. Found in at least one symptomatic patient, and not found in general population data. Moderate co-segregation with disease.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CAPN3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000070.2:c.483del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6347501</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2297707" SubmissionDate="2019-10-03" DateLastUpdated="2020-03-01" DateCreated="2020-03-01">
        <ClinVarSubmissionID localKey="MIST037_2|OMIM:253600" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001164493" DateUpdated="2020-03-01" DateCreated="2020-03-01" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The heterozygous p.Ile162SerfsTer17 variant in CAPN3 was identified by our study in the compound heterozygous state, with another pathogenic variant, in one individual with limb-girdle muscular dystrophy (LGMD). The presence of this variant in combination with a pathogenic variant and in an individual with LGMD increases the likelihood that the p.Ile162SerfsTer17 variant is pathogenic. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at position 162 and leads to a premature termination codon 17 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the CAPN3 gene is an established disease mechanism in autosomal recessive LGMD. In summary, this variant meets criteria to be classified as pathogenic for LGMD in an autosomal recessive manner based on the predicted impact of the variant and the presence of another pathogenic variant in one individual with LGMD. ACMG/AMP Criteria applied: PM2, PVS1, PM3 (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>WES</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CAPN3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="-" referenceAllele="G" start="42678466" stop="42678466" variantLength="1" />
          </Location>
          <OtherNameList>
            <Name>p.Ile162SerfsTer17</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253600" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6387569</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7864580" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000070.3:c.483del|OMIM:618129" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004213761" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000070.3:c.483del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="618129" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4247556" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4921530|MedGen:C1869123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002237073" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10330340</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15689361</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16650086</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ile162Serfs*17) in the CAPN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with limb girdle muscular dystrophy type 2 (PMID: 16650086). ClinVar contains an entry for this variant (Variation ID: 217156). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CAPN3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.42678466del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1869123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7864580" TraitType="Disease" MappingType="XRef" MappingValue="618129" MappingRef="OMIM">
        <MedGen CUI="C4748295" Name="Muscular dystrophy, limb-girdle, autosomal dominant 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4247556" TraitType="Disease" MappingType="XRef" MappingValue="C1869123" MappingRef="MedGen">
        <MedGen CUI="C1869123" Name="Autosomal recessive limb-girdle muscular dystrophy type 2A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="476464" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2297707" TraitType="Disease" MappingType="XRef" MappingValue="253600" MappingRef="OMIM">
        <MedGen CUI="C1869123" Name="Autosomal recessive limb-girdle muscular dystrophy type 2A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

